Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment

Objectives. To investigate the possibility of predicting recurrence of bladder tumors based on the clinical and morphological features of the disease and preoperative intravesical instillation of probiotic Aerococcus viridans 167. 190 patients operated for bladder tumors have been observed for a per...

Full description

Bibliographic Details
Main Authors: Molchanov R.N., Blyuss O.B.
Format: Article
Language:English
Published: SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine" 2015-03-01
Series:Medičnì Perspektivi
Subjects:
Online Access:http://medpers.dsma.dp.ua/issues/2015/N1/49-55.pdf
id doaj-733d9ba6f6544951bb591f732b75e799
record_format Article
spelling doaj-733d9ba6f6544951bb591f732b75e7992020-11-25T02:45:28ZengSE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"Medičnì Perspektivi2307-04042307-04042015-03-012014955Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatmentMolchanov R.N.0Blyuss O.B. 1SE «Dnipropetrovsk medical academy of Health Ministry of Ukraine»University Сollege London, Institute for Women’s Health, Department of Women's Cancer Objectives. To investigate the possibility of predicting recurrence of bladder tumors based on the clinical and morphological features of the disease and preoperative intravesical instillation of probiotic Aerococcus viridans 167. 190 patients operated for bladder tumors have been observed for a period from 1 to 73 months (mean 35.2 months). In 51 patients one single preoperative intravesical instillation of probiotic Aerococcus viridans 167 was added to a standard treatment. Reported cases of recurrence of tumors were used as a basis for the development of mathematical rules for predicting recurrences. These rules have been used to create a logistic regression and support vector machines. Of 190 patients, in 132 (69,5%) transitional cell carcinoma (TCC) in the stage Ta-T1, in 58 (30,5%) - transitional cell papilloma of the bladder (TCP) was identified. Recurrences were detected in 52 (27.4%) patients, mean time of observation was 14.7 (1-50 months). In patients with TCC recurrence was observed in 36 (37%) of 96 patients not treated with probiotic instillation vs 7 (19%) of 36 after probiotic use (p> 0,05). In TCP group no significant signs of the instillation influence of probiotics on the number of relapses were revealed. Classification rules that can predict the risk of recurrence of bladder tumors based on histological characteristics and application of probiotic were obtained. Preoperative instillation of probiotic Aerococcus viridans 167 in TCC TaT1 patients reduces the recurrence rate from 37% to 19% (p <0,05). Variables "Number of tumors" and "Maximum tumor size," and their relationship are informative prognostic parameters. The rules obtained may be recommended to follow up patients after surgery for timely distinguishing group of patients with increased risk of bladder tumor recurrence.http://medpers.dsma.dp.ua/issues/2015/N1/49-55.pdftumorsurinary bladderprognosisrecurrenceinfectionprobiotics
collection DOAJ
language English
format Article
sources DOAJ
author Molchanov R.N.
Blyuss O.B.
spellingShingle Molchanov R.N.
Blyuss O.B.
Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
Medičnì Perspektivi
tumors
urinary bladder
prognosis
recurrence
infection
probiotics
author_facet Molchanov R.N.
Blyuss O.B.
author_sort Molchanov R.N.
title Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
title_short Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
title_full Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
title_fullStr Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
title_full_unstemmed Prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
title_sort prediction of bladder tumor relapse based on the risk factors and characteristics of the treatment
publisher SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
series Medičnì Perspektivi
issn 2307-0404
2307-0404
publishDate 2015-03-01
description Objectives. To investigate the possibility of predicting recurrence of bladder tumors based on the clinical and morphological features of the disease and preoperative intravesical instillation of probiotic Aerococcus viridans 167. 190 patients operated for bladder tumors have been observed for a period from 1 to 73 months (mean 35.2 months). In 51 patients one single preoperative intravesical instillation of probiotic Aerococcus viridans 167 was added to a standard treatment. Reported cases of recurrence of tumors were used as a basis for the development of mathematical rules for predicting recurrences. These rules have been used to create a logistic regression and support vector machines. Of 190 patients, in 132 (69,5%) transitional cell carcinoma (TCC) in the stage Ta-T1, in 58 (30,5%) - transitional cell papilloma of the bladder (TCP) was identified. Recurrences were detected in 52 (27.4%) patients, mean time of observation was 14.7 (1-50 months). In patients with TCC recurrence was observed in 36 (37%) of 96 patients not treated with probiotic instillation vs 7 (19%) of 36 after probiotic use (p> 0,05). In TCP group no significant signs of the instillation influence of probiotics on the number of relapses were revealed. Classification rules that can predict the risk of recurrence of bladder tumors based on histological characteristics and application of probiotic were obtained. Preoperative instillation of probiotic Aerococcus viridans 167 in TCC TaT1 patients reduces the recurrence rate from 37% to 19% (p <0,05). Variables "Number of tumors" and "Maximum tumor size," and their relationship are informative prognostic parameters. The rules obtained may be recommended to follow up patients after surgery for timely distinguishing group of patients with increased risk of bladder tumor recurrence.
topic tumors
urinary bladder
prognosis
recurrence
infection
probiotics
url http://medpers.dsma.dp.ua/issues/2015/N1/49-55.pdf
work_keys_str_mv AT molchanovrn predictionofbladdertumorrelapsebasedontheriskfactorsandcharacteristicsofthetreatment
AT blyussob predictionofbladdertumorrelapsebasedontheriskfactorsandcharacteristicsofthetreatment
_version_ 1724762544548085760